SCHEMBL9516708

SCHEMBL9516708

O=CCC(c1cccc(F)c1)S(=O)(=O)NC(=O)c1ccc(CO)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.37
SLC6A5 Q9Y345 1/20 0.37
HDAC6 Q9UBN7 2/20 0.37
HDAC4 P56524 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC5 Q9UQL6 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CASP3 P42574 6/20 0.36
P4HTM Q9NXG6 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9515545 0.90 HDAC6 (0.36) SLC6A9SLC6A5HDAC6HDAC4HDAC7
SCHEMBL9515632 0.88 MEN1 (0.38) HDAC6HDAC4HDAC7HDAC5HDAC3
SCHEMBL9519433 0.88 NAMPT (0.39) SLC6A9HDAC6HDAC5HDAC3HDAC1
SCHEMBL9517025 0.86 CASP3 (0.39) SLC6A9SLC6A5HDAC6HDAC4HDAC7
SCHEMBL9517183 0.84 LMNA (0.38) HDAC6HDAC4HDAC7HDAC5HDAC3
SCHEMBL9516948 0.84 P4HTM (0.37) HDAC6HDAC4HDAC1MEN1NPC1
SCHEMBL9519668 0.82 EGFR (0.42) HDAC6HDAC4HDAC7HDAC5HDAC3
SCHEMBL9516276 0.81 HIF1A (0.39) HDAC6HDAC4HDAC7HDAC5HDAC3
SCHEMBL9517030 0.79 SLC6A9 (0.39) SLC6A9SLC6A5HDAC6HDAC4HDAC7
SCHEMBL9515429 0.79 HDAC1 (0.38) SLC6A9HDAC6HDAC5HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed